Cerebral palsy, regenerative brain disease Stem cells

What is it about?

This systematic review highlights the growing potential of regenerative medicine as an adjunctive therapy for children with cerebral palsy (CP). Analyzing data from 18 studies, the review found that interventions—particularly those using umbilical cord-derived products—led to moderate motor improvements, with combination therapies yielding the most promising benefits for both motor and cognitive outcomes. While the majority of adverse events were mild and transient, the review underscores the need for larger, longer-term studies to fully establish the safety and efficacy of these innovative approaches.

Featured Image